SI-BONE price to book ratio SIBN
Market value divided by the book value of the company's net assets, since 2019.
- Today, Oct 23, 2026
- 5.3×
- 8-year median
- 4.8×
- Against its 8-year history
- 65th
- percentile: 0 is its lowest day, 100 its highest
- 8-year range
- 3.0× to 10.8×
- Peer median
- 2.9×
SI-BONE's price to book ratio is 5.3× as of Oct 23, 2026.
That is above its 8-year median of 4.8×, higher than on 65% of days in the last 8 years.
Over that time it ranged from 3.0× in Jun 2024 to 10.8× in Jun 2023.
The median for 10 medical instruments and supplies stocks of a similar size is 2.9×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 5.3× | 3.1× | 5.3× |
| 2025 | 5.1× | 3.4× | 5.1× |
| 2024 | 3.5× | 3.0× | 4.9× |
| 2023 | 4.9× | 3.7× | 10.8× |
| 2022 | 4.6× | 3.5× | 5.8× |
| 2021 | 5.2× | 4.4× | 10.3× |
| 2020 | 9.5× | 3.6× | 9.6× |
| 2019 | 7.7× | 4.1× | 7.7× |
Against its peers
Companies in Medical - Instruments & Supplies nearest SI-BONE's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| SIBNSI-BONE | 5.3× |
| IRMDIradimed | 10.8× |
| STAAStaar Surgical | 3.1× |
| BVSBioventus | 5.5× |
| CDRECadre | 3.7× |
| MOVMovado | 1.4× |
| EYENational Vision | 1.6× |
| MDXGMimedx | 2.6× |
| TCMDTactile Systems Technology | 2.4× |
| LMATLemaitre Vascular | 4.6× |
| INSPInspire Medical Systems | 2.5× |
| Peer median | 2.9× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on SI-BONE
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.